AZB, D&D, Quillon act for PAG invest conglomerate in buy of Chennai’s Anjan Drug

Monday, 26 October 2020 By Legally India Corporate M&A

Gamot, an investment platform formed by private equity (PE) firm PAG along with PE funds CX Partners and Samara Capital has acquired a controlling stake in Chennai-based API manufacturer Anjan Drug.

— The Times of India

AZB & Partners advised PAG Asia Capital HK Limited led by a team of partners Ashwath Rau and Atreya Bhattacharya, senior associate Raina Upadhyay.

Desai & Diwanji advised bulk-drugs maker Anjan Drug led by a team of partner Siddarth Mody with senior associates Rahul Deodhar and Prerana Chaudhari.

Update 18 November: Quillon Partners represented CX Partners with a team led by partners Ankit Majmudar and Namrata Sinha with associate Stuti Khosla.

2020-08-01

Deal value: Confidential

{incomplete}

Comments

Guest 18 Nov 2020, 11:03

Troll

+13 -4

Sad to see AZB support the Chinese when we’re in a state of armed conflict with them on the border.

Guest 18 Nov 2020, 12:39

+13 -1

Why is this considered ‘trollish’? It doesn’t behoove one of India’s largest law firms to take enemy money at a time when there is a nationwide movement against Chinese imports.

Guest 18 Nov 2020, 13:34

+11 -1

They should consider donating the fees, net of expenses, to one of the Army relief funds. It’s really the least they can do.

Guest 18 Nov 2020, 14:43

+2 -9

We are? The PM doesn't say so. So are we supposed to believe the media about it now, and then disbelieve them when they report about the hash of a job the current government is making of our foreign relations? I'm just trying to figure out the wavelength along which your thought process works.

Guest 19 Nov 2020, 15:51

+1 -2

S Mody is a rockstar..highest performing partner of D&D...lets see how long he sticks there...heard he has resigned..and is on notice period..

Commenting is closed for this article.